Search result for 'formulations exports'

Natco Pharma reports a 23.44% drop in Q2 net profit to Rs 517.9 crore due to higher R&D and employee bonus. Revenue at Rs 1,363 crore.

NATCO Pharma shares tumbled 20% on Thursday after the company reported a 37.75% decline in consolidated net profit in the December quarter, driven by a drop in formulation exports.

NATCO Pharma's Q3 profit declined by 37.75% to Rs 132.4 crore due to a drop in formulations exports. Revenue also fell to Rs 474.8 crore.